← Back to Patent Explorer
US2789117A Expired / Lapsed US ⏱️ 0.0 years remaining

Belta1, 4-3, 20-11-oxygenated-17, 21-dihydroxypregnadiene 21-phosphates and 9-fluoro derivatives thereof

Assignee: Merck and Co Inc
•
Filing: 1955-01-14
•
Granted: 1957-04-16
•
Expires: 1975-01-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Lewis H Sarett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 04:46
CPC Classifications
C; C07; C07J; C07J5/00; C07J75/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 13 words
A COMPOUND SELECTED FROM THE GROUP CONSISTS OF COMPOUNDS HAVING THE FOLLOWING FORMULA:
Claim 2
Dependent Claim 13 words
A COMPOUND SELECTED FROM THE GROUP CONSISTS OF COMPOUNDS HAVING THE FOLLOWING FORMULA:

References Cited (Backward Citations)

US2183589A Cited
US2579479A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1960-04-15 1960-10-15 1961-04-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1964-04-15 1964-10-15 1965-04-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1968-04-15 1968-10-15 1969-04-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag